Revenue ForecastThe revenue forecast for 2025 has been lowered due to a slower than anticipated ramp-up, suggesting concerns about future financial performance.
Revenue PerformanceOverall sales in 1Q25 were significantly lower than expected, indicating potential challenges in meeting financial targets.
Unintended OutcomesSeveral alterations to the FemBloc procedure have led to unintended pregnancies, which are currently under evaluation in an ongoing pivotal study.